microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index

<h3>Background</h3><p dir="ltr">Despite several authors who have hypothesized that alterations of small noncoding RNAs (miR) are implicated in the etiopathogenesis of polycystic ovarian syndrome (PCOS), contrasting findings have been reported so far. Discrepancies in body...

Full description

Saved in:
Bibliographic Details
Main Author: Alexandra E. Butler (6189536) (author)
Other Authors: Vimal Ramachandran (8774123) (author), Thozhukat Sathyapalan (704787) (author), Rhiannon David (8774129) (author), Nigel J. Gooderham (704792) (author), Manasi Benurwar (8774132) (author), Soha R. Dargham (3613250) (author), Shahina Hayat (8774135) (author), S. Hani Najafi-Shoushtari (18812062) (author), Stephen L. Atkin (6684368) (author)
Published: 2020
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1864513512424865792
author Alexandra E. Butler (6189536)
author2 Vimal Ramachandran (8774123)
Thozhukat Sathyapalan (704787)
Rhiannon David (8774129)
Nigel J. Gooderham (704792)
Manasi Benurwar (8774132)
Soha R. Dargham (3613250)
Shahina Hayat (8774135)
S. Hani Najafi-Shoushtari (18812062)
Stephen L. Atkin (6684368)
author2_role author
author
author
author
author
author
author
author
author
author_facet Alexandra E. Butler (6189536)
Vimal Ramachandran (8774123)
Thozhukat Sathyapalan (704787)
Rhiannon David (8774129)
Nigel J. Gooderham (704792)
Manasi Benurwar (8774132)
Soha R. Dargham (3613250)
Shahina Hayat (8774135)
S. Hani Najafi-Shoushtari (18812062)
Stephen L. Atkin (6684368)
author_role author
dc.creator.none.fl_str_mv Alexandra E. Butler (6189536)
Vimal Ramachandran (8774123)
Thozhukat Sathyapalan (704787)
Rhiannon David (8774129)
Nigel J. Gooderham (704792)
Manasi Benurwar (8774132)
Soha R. Dargham (3613250)
Shahina Hayat (8774135)
S. Hani Najafi-Shoushtari (18812062)
Stephen L. Atkin (6684368)
dc.date.none.fl_str_mv 2020-04-28T09:00:00Z
dc.identifier.none.fl_str_mv 10.3389/fendo.2020.00206
dc.relation.none.fl_str_mv https://figshare.com/articles/journal_contribution/microRNA_Expression_in_Women_With_and_Without_Polycystic_Ovarian_Syndrome_Matched_for_Body_Mass_Index/26022322
dc.rights.none.fl_str_mv CC BY 4.0
info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv Biomedical and clinical sciences
Clinical sciences
Medical biochemistry and metabolomics
Reproductive medicine
microRNA
polycystic ovarian syndrome
follicular phase
menstrual cycle
insulin resistance
androgens
dc.title.none.fl_str_mv microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index
dc.type.none.fl_str_mv Text
Journal contribution
info:eu-repo/semantics/publishedVersion
text
contribution to journal
description <h3>Background</h3><p dir="ltr">Despite several authors who have hypothesized that alterations of small noncoding RNAs (miR) are implicated in the etiopathogenesis of polycystic ovarian syndrome (PCOS), contrasting findings have been reported so far. Discrepancies in body mass index (BMI) levels may account for these differences; therefore, the aim of the present study was to determine whether miR differed in serum samples collected from age- and BMI-matched control and PCOS women.</p><h3>Methods</h3><p dir="ltr">In a cross-sectional study, miR were measured using quantitative polymerase chain reaction in 29 women with anovulatory PCOS women and 29 control women who were in the follicular phase of their menstrual cycle, from the local biobank.</p><h3>Results</h3><p dir="ltr">One hundred seventy-six miR were detected, of which 15 miR passed the false discovery rate (FDR; p < 0.05) that differed between PCOS and control women. There was no association of the top 9 miR (p < 0.02) (miR-486-5p, miR-24-3p, miR-19b-3p, miR-22-3p, miR-19a-3p, miR-339-5p, miR-185-5p, miR-101-3p, miR-let-7i-5p) with BMI, androgen levels, insulin resistance, or antimullerian hormone (AMH) in either PCOS or normal women. Ingenuity pathway assessment showed the pathways were interrelated for abnormalities of the reproductive system.</p><h3>Conclusion</h3><p dir="ltr">When the confounding influence of weight was accounted for, miR levels differed between anovulatory PCOS women and control women in the follicular phase of the menstrual cycle. Interestingly, the differing miR were associated with the pathways of reproductive abnormalities but did not associate with AMH or metabolic parameters.</p><p dir="ltr">Corrigendum: microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index: <a href="https://dx.doi.org/10.3389/fendo.2020.00515" target="_blank">https://dx.doi.org/10.3389/fendo.2020.00515</a>, published online 30 July 2020.</p><h2>Other Information</h2><p dir="ltr">Published in: Frontiers in Endocrinology<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3389/fendo.2020.00206" target="_blank">https://dx.doi.org/10.3389/fendo.2020.00206</a></p>
eu_rights_str_mv openAccess
id Manara2_824d6c695d154d90256e36c561b4479e
identifier_str_mv 10.3389/fendo.2020.00206
network_acronym_str Manara2
network_name_str Manara2
oai_identifier_str oai:figshare.com:article/26022322
publishDate 2020
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv CC BY 4.0
spelling microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass IndexAlexandra E. Butler (6189536)Vimal Ramachandran (8774123)Thozhukat Sathyapalan (704787)Rhiannon David (8774129)Nigel J. Gooderham (704792)Manasi Benurwar (8774132)Soha R. Dargham (3613250)Shahina Hayat (8774135)S. Hani Najafi-Shoushtari (18812062)Stephen L. Atkin (6684368)Biomedical and clinical sciencesClinical sciencesMedical biochemistry and metabolomicsReproductive medicinemicroRNApolycystic ovarian syndromefollicular phasemenstrual cycleinsulin resistanceandrogens<h3>Background</h3><p dir="ltr">Despite several authors who have hypothesized that alterations of small noncoding RNAs (miR) are implicated in the etiopathogenesis of polycystic ovarian syndrome (PCOS), contrasting findings have been reported so far. Discrepancies in body mass index (BMI) levels may account for these differences; therefore, the aim of the present study was to determine whether miR differed in serum samples collected from age- and BMI-matched control and PCOS women.</p><h3>Methods</h3><p dir="ltr">In a cross-sectional study, miR were measured using quantitative polymerase chain reaction in 29 women with anovulatory PCOS women and 29 control women who were in the follicular phase of their menstrual cycle, from the local biobank.</p><h3>Results</h3><p dir="ltr">One hundred seventy-six miR were detected, of which 15 miR passed the false discovery rate (FDR; p < 0.05) that differed between PCOS and control women. There was no association of the top 9 miR (p < 0.02) (miR-486-5p, miR-24-3p, miR-19b-3p, miR-22-3p, miR-19a-3p, miR-339-5p, miR-185-5p, miR-101-3p, miR-let-7i-5p) with BMI, androgen levels, insulin resistance, or antimullerian hormone (AMH) in either PCOS or normal women. Ingenuity pathway assessment showed the pathways were interrelated for abnormalities of the reproductive system.</p><h3>Conclusion</h3><p dir="ltr">When the confounding influence of weight was accounted for, miR levels differed between anovulatory PCOS women and control women in the follicular phase of the menstrual cycle. Interestingly, the differing miR were associated with the pathways of reproductive abnormalities but did not associate with AMH or metabolic parameters.</p><p dir="ltr">Corrigendum: microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index: <a href="https://dx.doi.org/10.3389/fendo.2020.00515" target="_blank">https://dx.doi.org/10.3389/fendo.2020.00515</a>, published online 30 July 2020.</p><h2>Other Information</h2><p dir="ltr">Published in: Frontiers in Endocrinology<br>License: <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">https://creativecommons.org/licenses/by/4.0/</a><br>See article on publisher's website: <a href="https://dx.doi.org/10.3389/fendo.2020.00206" target="_blank">https://dx.doi.org/10.3389/fendo.2020.00206</a></p>2020-04-28T09:00:00ZTextJournal contributioninfo:eu-repo/semantics/publishedVersiontextcontribution to journal10.3389/fendo.2020.00206https://figshare.com/articles/journal_contribution/microRNA_Expression_in_Women_With_and_Without_Polycystic_Ovarian_Syndrome_Matched_for_Body_Mass_Index/26022322CC BY 4.0info:eu-repo/semantics/openAccessoai:figshare.com:article/260223222020-04-28T09:00:00Z
spellingShingle microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index
Alexandra E. Butler (6189536)
Biomedical and clinical sciences
Clinical sciences
Medical biochemistry and metabolomics
Reproductive medicine
microRNA
polycystic ovarian syndrome
follicular phase
menstrual cycle
insulin resistance
androgens
status_str publishedVersion
title microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index
title_full microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index
title_fullStr microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index
title_full_unstemmed microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index
title_short microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index
title_sort microRNA Expression in Women With and Without Polycystic Ovarian Syndrome Matched for Body Mass Index
topic Biomedical and clinical sciences
Clinical sciences
Medical biochemistry and metabolomics
Reproductive medicine
microRNA
polycystic ovarian syndrome
follicular phase
menstrual cycle
insulin resistance
androgens